AC
Applied Clinical Trials
ACT Brief: Community Trial Cost Barriers, Measuring What Matters, and Prostate Cancer Approval
0:00-1:52
In today’s ACT Brief, we examine how cost barriers and site infrastructure limit participation in community trials, why endpoints should reflect what patients actually experience, and how the FDA expanded a prostate cancer combination to an earlier treatment setting.
Publisher
Applied Clinical Trials
Link
audioboom.com/posts/8969492
Published
October 27, 2026
Duration
2 min
Format
Podcast
Category
Issues · Science
Source
RSS feed
AC
Applied Clinical Trials
@appliedclinicaltrials
#actbrief #communitytrialcost #prostatecancerapproval #lifesciences
